Homozygous Resistance to Thyroid Hormone β: Can Combined Antithyroid Drug and Triiodothyroacetic Acid Treatment Prevent Cardiac Failure?

Moran, C., Habeb, A.M., Kahaly, G.J. et al. (20 more authors) (2017) Homozygous Resistance to Thyroid Hormone β: Can Combined Antithyroid Drug and Triiodothyroacetic Acid Treatment Prevent Cardiac Failure? Journal of the Endocrine Society, 1 (9). pp. 1203-1212.

Abstract

Metadata

Authors/Creators:
  • Moran, C.
  • Habeb, A.M.
  • Kahaly, G.J.
  • Kampmann, C.
  • Hughes, M.
  • Marek, J.
  • Rajanayagam, O.
  • Kuczynski, A.
  • Vargha-Khadem, F.
  • Morsy, M.
  • Offiah, A.C. ORCID logo https://orcid.org/0000-0001-8991-5036
  • Poole, K.
  • Ward, K.
  • Lyons, G.
  • Halsall, D.
  • Berman, L.
  • Watson, L.
  • Baguley, D.
  • Mollon, J.
  • Moore, A.T.
  • Holder, G.E.
  • Dattani, M.
  • Chatterjee, K.
Copyright, Publisher and Additional Information: This article has been published under the terms of the Creative Commons Attribution License (CC BY; https://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. Copyright for this article is retained by the author(s).
Keywords: cardiac thyrotoxicosis; homozygous THRB mutation; resistance to thyroid hormone
Dates:
  • Published: 1 September 2017
  • Published (online): 8 August 2017
  • Accepted: 1 August 2017
Institution: The University of Sheffield
Academic Units: The University of Sheffield > Faculty of Medicine, Dentistry and Health (Sheffield) > School of Medicine (Sheffield) > Division of Genomic Medicine (Sheffield) > Department of Oncology (Sheffield)
Depositing User: Symplectic Sheffield
Date Deposited: 03 Jan 2018 10:11
Last Modified: 03 Jan 2018 10:11
Published Version: https://doi.org/10.1210/js.2017-00204
Status: Published
Publisher: Oxford University Press
Refereed: Yes
Identification Number: https://doi.org/10.1210/js.2017-00204
Related URLs:

Download

Share / Export

Statistics